Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are having a type of heart attack called a STEMI (where a specific pattern is seen on a heart tracing), with symptoms that started less than 24 hours ago or that are still ongoing.
- People who have read and signed a consent form agreeing to take part.
Who may not be able to join:
- People younger than 18 or older than 70 years of age.
- People who are pregnant or breastfeeding.
- People whose heart is in a state of severe failure known as cardiogenic shock (where the heart cannot pump enough blood to meet the body's needs).
- People whose kidneys are not working well enough (below a certain threshold), unless they are already on dialysis — patients already on regular dialysis may still be considered eligible (confirm with trial site).
- People whose affected heart artery is too narrow or too wide in certain measurements taken during the procedure.
- People where a preparatory balloon procedure inside the artery still leaves a significant blockage of more than 30% remaining.
- People where the blocked section of the artery is longer than 21 mm.
- People where the blockage is located inside a stent that was placed in a previous procedure.
- People where the blockage is in a bypass graft taken from a leg vein (called a saphenous vein graft).
- People where the blocked area is at a branching point in the artery that would require two stents to be placed.
- People where the blockage is at the very opening of the right coronary artery.
- People where the affected artery has severe hardening (calcification) or twisting that makes the procedure more difficult.
- People who have a medical reason why they cannot safely take two blood-thinning medications together for 12 months.
- People whose life expectancy is less than 3 years.
- People who are currently taking blood-thinning tablets (oral anticoagulants).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +3216342465
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
A device oriented composite endpoint (DOCE) including cardiac death, target vessel myocardial infarction (attributable to the culprit lesion) and ischemic-driven target lesion revascularization (TLR) within 12 months after the index procedure.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.